This PDF is the current document as it appeared on Public Inspection on 03/19/2014 at 08:45 am.
Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal of approval of a new animal drug application (NADA) and two abbreviated new animal drug applications (ANADAs) for three-way, fixed-ratio combination drug Type A medicated articles containing chlortetracycline, sulfathiazole, and penicillin. This action is being taken at the sponsor's request because these products are no longer manufactured or marketed.
This rule is effective March 31, 2014.Start Further Info
FOR FURTHER INFORMATION CONTACT:
David Alterman, Center for Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-453-6843.End Further Info End Preamble Start Supplemental Information
Zoetis Inc., 333 Portage St., Kalamazoo, MI 49007 has requested that FDA withdraw approval of the following NADA and two ANADAs because the products are no longer manufactured or marketed:
|039-077||CSP 250 (chlortetracycline, sulfathiazole, and penicillin) Type A medicated article.|
|200-140||AUREOZOL (chlortetracycline, sulfathiazole, and penicillin) Type A medicated article.|
|200-167||AUREOZOL 500 Granular (chlortetracycline, sulfathiazole, and penicillin) Type A medicated article.|
The NADAs listed were identified as being affected by guidance for industry (GFI) #213, “New Animal Drugs and New Animal Drug Combination Products Administered in or on Medicated Feed or Drinking Water of Food-Producing Animals: Recommendations for Drug Sponsors for Voluntarily Aligning Product Use Conditions with GFI #209”, December 2013.
Elsewhere in this issue of the Federal Register, FDA gave notice that approval of NADA 039-077, ANADA 200-140, and ANADA 200-167, and all supplements and amendments thereto, is withdrawn, effective March 31, 2014. As provided in the regulatory text of this document, the animal drug regulations are amended to reflect these voluntary withdrawals of approval.
This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.Start List of Subjects
List of Subjects in 21 CFR Part 558
- Animal drugs
- Animal feeds
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is amended as follows:Start Part
PART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDSEnd Part Start Amendment Part
1. The authority citation for 21 CFR part 558 continues to read as follows:End Amendment Part
2. In § 558.4(d), in the “Category II” table, remove the entry for “Sulfathiazole” and its respective following entries.End Amendment Part
3. Remove § 558.155.End Amendment Part Start Signature
Dated: March 12, 2014.
Director, Center for Veterinary Medicine.
[FR Doc. 2014-05882 Filed 3-19-14; 8:45 am]
BILLING CODE 4160-01-P